⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,711.17
+0.27%
Nasdaq 100
29,528.12
+0.00%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$216.99
−0.05%
NYSE:TSM
$427.08
+1.63%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,122.02
−0.45%
Brent
$108.96
−0.23%
BTC
$82,689.48
+1.03%
ETH
$2,448.08
+1.78%
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,711.17
+0.27%
Nasdaq 100
29,528.12
+0.00%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$216.99
−0.05%
NYSE:TSM
$427.08
+1.63%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,122.02
−0.45%
Brent
$108.96
−0.23%
BTC
$82,689.48
+1.03%
ETH
$2,448.08
+1.78%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Open
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Mineralys Therapeutics Inc · News · TradingHolo
Markets
›
United States
› NAS
› MLYS
M
Mineralys Therapeutics Inc
NAS:MLYS
Healthcare
CBOEFTSE:MRUT
NASDAQ:NBI
$21.43
+2.41%
Live
In session · ≈
AED 78.68
· Market cap
$1.89B
· Next earnings
Mon 9 Nov
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
MLYS news
Headlines tagged to this company
RE
Mineralys Therapeutics Expands Its Board Of Directors With The Appointments Of Kristine Peterson And Lonnel Coats
Reuters · 19 h ago
TR
Mineralys Therapeutics, Inc. (MLYS) Adds Two Directors Ahead of PDUFA
TradingView · 21 h ago
SE
Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q3
Seeking Alpha · 7 d ago
DO
Mineralys Therapeutics Price Target Announced at $29.00/Share by UBS
Dow Jones Newswires · 8 d ago
DO
Mineralys Therapeutics Price Target Maintained With a $56.00/Share by HC Wainwright & Co.
Dow Jones Newswires · 8 d ago
TR
HC Wainwright & Co. reiterates Buy rating on Mineralys Therapeutics, $56 price target
TradingView · 8 d ago
TR
Mineralys Therapeutics, Inc. (MLYS) Reports Lorundrostat Cut SBP; 46% Hit <130 mmHg at 12 Weeks
TradingView · 11 d ago
GL
Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026
GlobeNewswire · 18 d ago
GL
Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026
GlobeNewswire · 19 d ago
QU
MLYS: Lorundrostat nears launch with strong clinical data, broad access plans, and high strategic interest
Quartr · 20 d ago
QU
MLYS: Lorundrostat is poised for launch with strong clinical data and broad market access strategies
Quartr · 20 d ago
GL
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · 21 d ago
GL
Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
globenewswire · 26 d ago
GL
Mineralys Therapeutics’ Transform-HTN Open-Label Extension Trial Data Selected for Late-Breaking Presentation at American Heart Association Scientific Sessions 2026
globenewswire · 27 d ago
GL
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire · 29 d ago
GL
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire · 41 d ago
MA
Mineralys Therapeutics Q2 Earnings Call Highlights
MarketBeat · 70 d ago
GL
Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewsWire · 70 d ago
End of the feed